- Title
- Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
- Creators
- P MASLAK - Department of Clinical Laboratories, New York, NY, United StatesS CHANEL - Department of Medicine, Memorial Hospital, New York, NY, United StatesL. H CAMACHO - Department of Medicine, Memorial Hospital, New York, NY, United StatesS SOIGNET - Department of Medicine, Memorial Hospital, New York, NY, United StatesP. P PANDOLFI - The Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, United StatesI GUERNAH - The Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, United StatesR WARRELL - Department of Medicine, Memorial Hospital, New York, NY, United StatesS NIMER - Department of Medicine, Memorial Hospital, New York, NY, United States
- Publication Details
- Leukemia, Vol.20(2), pp.212-217
- Publisher
- Nature Publishing; London
- Academic Unit
- Leadership Department; Miller School of Medicine; Sylvester Comprehensive Cancer Center
- Language
- English
- Resource Type
- Journal article
- PMID
- 16357841
- Record Identifier
- 991031560135602976
Journal article
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
Leukemia, Vol.20(2), pp.212-217
2006
PMID: 16357841
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis
- 1.25.1461 Histone Deacetylase
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites